CAS 1251765-07-7

Fórmula: C14H22N6O4S

InChI: InChI=1S/C14H22N6O4S/c1-2-5-25-14-16-12(15)9-13(17-14)20(19-18-9)7-6-8(24-4-3-21)11(23)10(7)22/h7-8,10-11,21-23H,2-6H2,1H3,(H2,15,16,17)/t7-,8+,10+,11-/m1/s1

Chave InChI: YTYBSYIHUFBLKV-YKDSUIRESA-N

SMILES: CCCSC1=NC(=C2C(=N1)N(N=N2)[C@@H]3C[C@@H]([C@H]([C@H]3O)O)OCCO)N

Ticagrelor Amine

CAS: 1251765-07-7

Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoi

Fórmula: C₁₄H₂₂N₆O₄S

Cor e Forma: Off-White Powder

Peso molecular: 370.14232

Ref: 45-1A13030

(1S,2S,3R,5S)-3-(7-Amino-5-(Propylthio)-3H-[1,2,3]Triazolo[4,5-D]Pyrimidin-3-Yl)-5-(2-Hydroxyethoxy)Cyclopentane-1,2-Diol

CAS: 1251765-07-7

(1S,2S,3R,5S)-3-(7-Amino-5-(Propylthio)-3H-[1,2,3]Triazolo[4,5-D]Pyrimidin-3-Yl)-5-(2-Hydroxyethoxy)Cyclopentane-1,2-Diol

Fórmula: C₁₄H₂₂N₆O₄S

Pureza: 98%

Peso molecular: 370.43

Ref: 54-OR1023044

Ticagrelor EP Impurity A

CAS: 1251765-07-7

Fórmula: C₁₄H₂₂N₆O₄S

Cor e Forma: White To Off-White Solid

Peso molecular: 370.43

Ref: 4Z-T-8160

Ticagrelor metabolite M5

CAS: 1251765-07-7

Ticagrelor metabolite M5

Fórmula: C₁₄H₂₂N₆O₄S

Pureza: ≥98%

Peso molecular: 370.43

Ref: 54-BUP02360

(1S,2S,3R,5S)-3-(7-Amino-5-(Propylthio)-3H-[1,2,3]Triazolo[4,5-D]Pyrimidin-3-Yl)-5-(2-Hydroxyethoxy)Cyclopentane-1,2-Diol

CAS: 1251765-07-7

Fórmula: C₁₄H₂₂N₆O₄S

Pureza: 99%

Cor e Forma: Solid

Peso molecular: 370.4273

Ref: IN-DA009C5Y

AR-C133913XX

Produto Controlado

CAS: 1251765-07-7

Stability Hygroscopic
Applications AR-C133913XX is an metabolte of Ticagrelor (T437700) which is the first reversible oral P2Y12 receptor antagonist, provides faster, greater, and more consistent ADP-receptor inhibition than Clopidogrel. Ticagrelor is used in the treatment of acute coronary syndromes (ACS).
References Matetzky, S., et al.: Circulation, 109, 3171 (2004); Bassand, J., et al.: Eur. Heart J., 28, 1598 (2007); Jakubowski, J., et al.: Cardiovasc. Drug Rev., 25, 357 (2007)

Fórmula: C₁₄H₂₂N₆O₄S

Cor e Forma: Neat

Peso molecular: 370.43

Ref: TR-A766550

Ticagrelor metabolite M5

CAS: 1251765-07-7

Ticagrelor metabolite M5 (T437700) is a metabolite of Ticagrelor, the first reversible oral antagonist of P2Y12 receptor.

Fórmula: C₁₄H₂₂N₆O₄S

Pureza: 99.35%

Cor e Forma: Solid

Peso molecular: 370.427

Ref: TM-T21059

Ticagrelor EP Impurity A

CAS: 1251765-07-7

Fórmula: C₁₄H₂₂N₆O₄S

Peso molecular: 370.43

Ref: ST-EA-CP-T21001

AR-C133913XX

CAS: 1251765-07-7

AR-C133913XX is a dietary supplement that belongs to the group of drugs known as adenosine receptor antagonists. It is used to treat cardiovascular diseases such as hypertension, coronary artery disease, and heart failure. AR-C133913XX reversibly blocks the A2A adenosine receptor in the caco-2 cells in order to reduce blood flow and increase vasoconstriction. This drug also has antiplatelet properties, which are due to its ability to inhibit platelet aggregation. AR-C133913XX is metabolized by glucuronidation and eliminated by renal excretion.

Fórmula: C₁₄H₁₅N₆O₄S

Pureza: Min. 95%

Cor e Forma: Powder

Peso molecular: 370.43 g/mol

Ref: 3D-BAC76507

Ticagrelor metabolite M5

CAS: 1251765-07-7

Fórmula: C₁₄H₂₂N₆O₄S

Peso molecular: 370.43

Ref: BE-RMCT186230

Ticagrelor metabolite M5

CAS: 1251765-07-7

(1S,2S,3R,5S)-3-(7-amino-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol

Fórmula: C₁₄H₂₂N₆O₄S

Pureza: 99%

Peso molecular: 370.43

Ref: IN-DG00791078

(1S,2S,3R,5S)-3-(7-amino-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol

CAS: 1251765-07-7

Pureza: 99%

Peso molecular: 370.4299927

Ref: 10-F789339

AR-C133913XX-d7

Produto Controlado

CAS: 1251765-07-7

Fórmula: C₁₄D₇H₁₅N₆O₄S

Cor e Forma: Neat

Peso molecular: 377.47

Ref: TR-A766552